| Vmoto Limited (VMT) ORDINARY FULLY PAID |
Consumer Discretionary |
$24 |
VMT Review Panel Declines to Conduct Proceedings
|
18 Mar 2025 10:05AM |
$0.080 |
$0.061 |
fallen by
23.75%
|
|
VMT - Price-sensitive ASX Announcement
Full Release
Key Points
- Vmoto Limited review panel declines to conduct proceedings on application from Munro Family Super Fund.
- Panel finds issues raised are more appropriate for courts or ASIC.
- Concerns noted over lack of substantial holder notices from top shareholders.
- Panel to refer shareholder notice issues to ASIC for investigation.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Terra Critical Minerals Limited (T92) ORDINARY FULLY PAID |
Energy |
$17 |
Suspension from Quotation
|
18 Mar 2025 10:05AM |
$0.038 |
$0.115 |
risen by
202.63%
|
|
T92 - Price-sensitive ASX Announcement
Full Release
Key Points
- Terra Uranium Limited requested a suspension of quotation for its shares.
- The suspension is under ASX Listing Rule 17.2.
- It is pending an announcement regarding an acquisition and capital raising.
- The company plans to make the announcement before normal trading resumes on 19 March 2025.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| The Hydration Pharmaceuticals Company Limited (HPC) ORDINARY FULLY PAID |
Consumer Staple |
$2 |
Strategic Placement and Rights Issue to Raise up to $1.25m
|
18 Mar 2025 10:03AM |
$0.009 |
$0.005 |
fallen by
44.44%
|
|
HPC - Price-sensitive ASX Announcement
Full Release
Key Points
- Firm commitments to raise $650,000 via strategic placement to Mr Joseph Constable and another investor.
- 60 million Placement Shares to Mr Constable will provide proceeds of $600,000.
- The remaining 5 million Shares will be allocated to another investor for $50,000.
- Rights Issue will seek to raise an additional ~$610,000.
- Funds will support sales momentum from continuing US operations.
- January and February 2025 YTD net sales of US$489K, up 19% on previous corresponding period.
- Gross margin increased to 64% from 62% for CY2024.
- Transition Services Agreement with Prestige Consumer Healthcare Inc. completed on 15 February 2025.
- Significant operational expenditure reductions expected from mid-March 2025.
- Management expects improvements in gross margin and reduction in operational expenditures in CY2025.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| MEC Resources Limited (MMR) ORDINARY FULLY PAID |
Energy |
$7 |
PEP11 Update - Federal Court Proceedings
|
18 Mar 2025 10:02AM |
$0.004 |
$0.004 |
fallen by
0%
|
|
MMR - Price-sensitive ASX Announcement
Full Release
Key Points
- MEC Resources highlights its 37.95% stake in Advent Energy Ltd.
- The PEP 11 Joint Venture consists of Advent and Bounty Oil and Gas Limited.
- The National Offshore Petroleum Titles Administrator refused joint venture applications made on 23 January 2020 and 17 March 2021.
- Asset Energy Pty Ltd filed an Originating Application for judicial review regarding the refusal decision.
- The Federal Court set deadlines for document submissions and hearing schedules.
- A 2-day hearing is set for 16 and 17 September 2025.
- The court has suspended the operation of the decision made by the Joint Authority until further notice.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Orthocell Limited (OCC) ORDINARY FULLY PAID |
Health Care |
$220 |
Regulatory approval to commence Striate sales in Singapore
|
18 Mar 2025 9:59AM |
$1.370 |
$0.810 |
fallen by
40.88%
|
|
OCC - Price-sensitive ASX Announcement
Full Release
Key Points
- Orthocell receives regulatory approval for Striate+ in Singapore.
- Approval complements existing clearances in several countries.
- Singapore serves as a key regulatory hub for ASEAN markets.
- BioHorizons is Orthocell's global marketing partner for Striate+.
- Striate+ has shown robust sales growth and positive feedback from dental surgeons.
- The global market opportunity for Striate+ is estimated at over AU$1 billion.
- Orthocell is well-funded with approximately AU$33 million in cash.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| GWA Group Limited (GWA) ORDINARY FULLY PAID |
Industrials |
$575 |
Change of Director's Interest Notice
|
18 Mar 2025 9:59AM |
$2.270 |
$2.170 |
fallen by
4.41%
|
|
| Catalina Resources Ltd (CTN) ORDINARY FULLY PAID |
Materials |
$11 |
Application for quotation of securities - CTN
|
18 Mar 2025 9:56AM |
$0.003 |
$0.080 |
risen by
2,566.67%
|
|
| Prospech Limited (PRS) ORDINARY FULLY PAID |
Materials |
$7 |
Korsnas Delivers High-Grade Heavy REE Intercepts
|
18 Mar 2025 9:55AM |
$0.025 |
$0.013 |
fallen by
48%
|
|
PRS - Price-sensitive ASX Announcement
Full Release
Key Points
- Prospech Limited focuses on mineral exploration in Finland and Slovakia.
- The company aims to discover and develop critical elements deposits.
- The Korsnäs project shows continuity and extent of high-grade REE mineralisation.
- Latest assays include significant intercepts over 1% TREO.
- High-grade results reach up to 4.6% TREO.
- Notable heavy REE enrichments include Terbium up to 61.3 ppm and Dysprosium up to 234.2 ppm.
- 4,035 samples analyzed from 237 drill holes covering 6,453 metres.
- Mineral Resource Estimate is being updated to reflect recent findings.
- Exploration upside potential is significant, confirming continuity at depth and along strike.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Chimeric Therapeutics Limited (CHM) ORDINARY FULLY PAID |
Health Care |
$3 |
Update - Proposed issue of securities - CHM
|
18 Mar 2025 9:55AM |
$0.006 |
$0.002 |
fallen by
66.67%
|
|
| Dropsuite Limited (DSE) ORDINARY FULLY PAID |
Information Technology |
- |
Update in relation to Topline Capital Partners LP
|
18 Mar 2025 9:54AM |
$5.750 |
$5.880 |
risen by
2.26%
|
|
DSE - Price-sensitive ASX Announcement
Full Release
Key Points
- Topline Capital Partners LP holds approximately 7.36 million shares in Dropsuite.
- This represents about 10.47% of the issued capital in Dropsuite.
- Topline Capital previously held 13,829,409 shares, approximately 19.7% of issued capital.
- Topline Capital remains supportive of the transaction with NinjaOne.
- The announcement was approved by the Board of Directors.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Wide Open Agriculture Ltd (WOA) ORDINARY FULLY PAID |
Consumer Staple |
$10 |
Presentation to Food and Ingredients China 2025 Conference
|
18 Mar 2025 9:54AM |
$0.028 |
$0.016 |
fallen by
42.86%
|
|
| DomaCom Limited (DCL) ORDINARY FULLY PAID |
Financials |
- |
Change in substantial holding
|
18 Mar 2025 9:54AM |
$0.011 |
$0.011 |
fallen by
0%
|
|
| Tower Limited (TWR) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Financials |
$517 |
Trading Halt
|
18 Mar 2025 9:51AM |
$1.315 |
$1.505 |
risen by
14.45%
|
|
TWR - Price-sensitive ASX Announcement
Full Release
Key Points
- Tower Limited's securities will be placed in trading halt at the company's request.
- The halt is due to a capital return through a court-approved scheme.
- Approximately NZD 45 million will be returned to shareholders.
- For every 10 shares held, shareholders will have 1 share cancelled.
- Shareholders will receive NZD 1.1858 for each cancelled share.
- The trading halt starts on 18 March 2025 and ends on 20 March 2025.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Larvotto Resources Limited (LRV) ORDINARY FULLY PAID |
Materials |
$656 |
Proposed issue of securities - LRV
|
18 Mar 2025 9:50AM |
$0.860 |
$1.265 |
risen by
47.09%
|
|
| Green Technology Metals Limited (GT1) ORDINARY FULLY PAID |
Materials |
$22 |
Prospectus
|
18 Mar 2025 9:49AM |
$0.039 |
$0.034 |
fallen by
12.82%
|
|
| Larvotto Resources Limited (LRV) ORDINARY FULLY PAID |
Materials |
$656 |
Purchase of Echidna Gully
|
18 Mar 2025 9:49AM |
$0.860 |
$1.265 |
risen by
47.09%
|
|
LRV - Price-sensitive ASX Announcement
Full Release
Key Points
- Larvotto Resources Limited is advancing multiple mineral projects.
- The Hillgrove Mine is expected to contribute significantly to the global antimony supply.
- The acquisition of Echidna Gully includes a $3 million cash payment.
- An additional 771,109 shares will be issued, valued at $600,000.
- The rise in antimony prices is driven by supply constraints and geopolitical factors.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Cygnus Metals Limited (CY5) ORDINARY FULLY PAID |
Materials |
$170 |
Strong drilling results point to resource growth and upgrade
|
18 Mar 2025 9:48AM |
$0.120 |
$0.160 |
risen by
33.33%
|
|
CY5 - Price-sensitive ASX Announcement
Full Release
Key Points
- Cygnus Metals Limited announced positive drill results from Chibougamau Copper-Gold Project.
- Infill drilling at Corner Bay showed intervals up to 5.6% CuEq.
- New target Colline demonstrated significant high-grade results.
- Drilling continued with two rigs focusing on resource growth.
- Colline is less than 4km from the central processing facility.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| RBR Group Limited (RBR) ORDINARY FULLY PAID |
Materials |
$2 |
Mozambique LNG Project Update
|
18 Mar 2025 9:46AM |
$0.001 |
$0.019 |
risen by
1,800%
|
|
RBR - Price-sensitive ASX Announcement
Full Release
Key Points
- US Export-Import Bank approved a nearly US$5 billion loan for Mozambique LNG Project.
- TotalEnergies operates the Mozambique LNG Project.
- This approval marks a crucial step in revitalizing the project.
- Mozambique is set to become a significant LNG producer.
- Rovuma LNG project, operated by ExxonMobil, is in progress.
- ExxonMobil aims to take final investment decision in the first half of 2026.
- RBR is seeing increased commercial enquiries and expressions of interest for LNG projects.
- RBR Group is positioned to capitalize on the lifting of force majeure at LNG projects.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Blue Star Helium Limited (BNL) ORDINARY FULLY PAID |
Energy |
$26 |
Jackson 4 Intermediate Section Drilling Complete
|
18 Mar 2025 9:43AM |
$0.006 |
$0.006 |
fallen by
0%
|
|
| Firebird Metals Limited (FRB) ORDINARY FULLY PAID |
Materials |
$44 |
FRB Granted Mining Lease for Oakover Manganese Project
|
18 Mar 2025 9:42AM |
$0.094 |
$0.240 |
risen by
155.32%
|
|
FRB - Price-sensitive ASX Announcement
Full Release
Key Points
- Firebird Metals Limited has been granted Mining Lease ML 52/1086 for the Oakover Manganese Project.
- The granted lease is subject to approval for a mining proposal from the Department of Energy, Mines, Industry Regulation and Safety.
- The Oakover Project has a Mineral Resource Estimate of 176.7 million tonnes at 9.9% manganese.
- The company aims to grow into a low-cost manganese-based cathode material business.
- Firebird plans to integrate manganese sulphate production from a proposed plant in China.
- The project is part of a strategy to secure a competitive advantage in the battery materials market.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Chimeric Therapeutics Limited (CHM) ORDINARY FULLY PAID |
Health Care |
$3 |
Prospectus
|
18 Mar 2025 9:42AM |
$0.006 |
$0.002 |
fallen by
66.67%
|
|
CHM - Price-sensitive ASX Announcement
Full Release
Key Points
- Chimeric Therapeutics Limited offers 2 new shares for every 5 existing shares at $0.005 each.
- The offer aims to raise approximately $3.2 million for ongoing clinical trials.
- Chimeric has multiple clinical programs, including CHM CDH17 and CHM CORE-NK.
- The prospectus highlights the company's focus on innovative cell therapies for cancer treatment.
- The offer closes on 8 April 2025.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Kali Metals Limited (KM1) ORDINARY FULLY PAID |
Materials |
$33 |
Kali Expands Pilbara Gold Tenure
|
18 Mar 2025 9:40AM |
$0.078 |
$0.170 |
risen by
117.95%
|
|
KM1 - Price-sensitive ASX Announcement
Full Release
Key Points
- Kali Metals Limited acquires tenements E45/6429 and E45/6430.
- Expansion of Marble Bar Project by ~19 km².
- Adjacent and contiguous to Kali’s existing Marble Bar Gold-Lithium Project.
- Gold-in-soil anomaly trend increased by 80% from 5.1 km to 9.5 km.
- Promising gold mineralization identified at Tiger and Sherman Prospects.
- Acquisition primarily consists of scrip consideration.
- Total consideration includes $30,000 cash and $200,000 in shares.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Chimeric Therapeutics Limited (CHM) ORDINARY FULLY PAID |
Health Care |
$3 |
Entitlement Offer to raise approximately $3.2 million
|
18 Mar 2025 9:39AM |
$0.006 |
$0.002 |
fallen by
66.67%
|
|
CHM - Price-sensitive ASX Announcement
Full Release
Key Points
- Non-renounceable entitlement offer to eligible shareholders to raise approximately $3.2 million.
- Offer price of $0.005 per new share on a 2 for 5 basis.
- 1 new option for every new share issued with an exercise price of $0.008 and expiry date of 19 December 2025.
- Funds will primarily be used for continued development of Chimeric’s CHM CDH17 Phase 1/2 clinical trial.
- Approximately 638 million New Shares will be issued as part of the Entitlement Offer.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Dropsuite Limited (DSE) ORDINARY FULLY PAID |
Information Technology |
- |
TOV: DSE Panel Receives Application
|
18 Mar 2025 9:38AM |
$5.750 |
$5.880 |
risen by
2.26%
|
|
DSE - Price-sensitive ASX Announcement
Full Release
Key Points
- The Takeovers Panel received an application regarding Dropsuite Limited.
- Harvest Lane Asset Management Pty Ltd submitted the application.
- The application relates to the proposed acquisition by NinjaOne, LLC.
- Topline Capital Management LLC's voting power in Dropsuite decreased from 31.0% to 19.7%.
- The applicant claims Topline's intention statement was misleading.
- The applicant seeks to prevent further share sales by Topline.
- The applicant wants Topline to vote its remaining shares in favor of the acquisition.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| BPH Energy Ltd (BPH) ORDINARY FULLY PAID |
Financials |
$11 |
PEP11 Update
|
18 Mar 2025 9:37AM |
$0.010 |
$0.008 |
fallen by
20%
|
|
Call 1300 880 160
Start a chat
Schedule a call
